Skip to main content

Table 3 Results of the univariate analyses per clinical outcome

From: Advancing current approaches to disease management evaluation: capitalizing on heterogeneity to understand what works and for whom

Clinical outcome Care groups (N) Patients (N) Mean difference [95% CI] Heterogeneity (I2)
HbA1c (mmol/mol) 18 75,127 0.17 [−0.60, 0.93] 98%*
LDL (mmol/l) 18 58,697 −0.09 [−0.13, -0.05]* 93%*
SBP (mmHg) 18 73,437 −0.95 [−1.25, -0.64]* 57%*
BMI (kg/m2) 18 63,341 −0.04 [−0.10, 0.02] 0%
  1. NOTE: * Statistically significant (p < 0.05).